Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Het Neurologisch Jaaroverzicht 2024
feb 2025 | Bewegingsstoornissen, Dementie, Hoofdpijn, Multipele Sclerose